Doxofylline

多索茶碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDoxofylline
Drug Alias Name凯宝川苧doxofyllinumdoxofylline多沙茶碱多索茶硷 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthmaBronchitis, Chronic
Global Approved IndicationsPulmonary Disease, Chronic ObstructiveAsthmaBronchitis, Chronic
Approved Indications in ChinaAsthmaBronchitis, Chronic
Original Approved Country/TerritoryItaly
Original Approved Date1988/10/01
Country/TerritoryItalyMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHeilongjiang Fuhe Huaxing Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthmaBronchitis, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeR03DA11
Related LinksWikipediaDrugBankKEGG